Idibell

Facial paralysis image processing software is awarded a grant by the Academy of Medical Sciences

Leave a Comment / Uncategorised / By

Researchers from the Rehabilitation and Physiotherapy Department of Bellvitge University Hospital – Bellvitge Biomedical Research Institute (HUB-IDIBELL) have been awarded the VI basic research in physiotherapy grant from the Catalan-Balearic Physiotherapy Society, which will allow them to partially fund the clinical validation of a imaging software prototype designed as a facial neuromuscular therapy in patients […]

Facial paralysis image processing software is awarded a grant by the Academy of Medical Sciences Read More »

The complete epigenomes of the most frequent tumors, unveiled

Leave a Comment / Uncategorised / By

A research team from the Bellvitge Biomedical Research Institute (IDIBELL) has managed to characterize the complete epigenomes of the most frequent tumors, including those of colon, lung and breast cancer. Their work, published in Oncogene, was led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA Researcher and Professor

The complete epigenomes of the most frequent tumors, unveiled Read More »

Starvation causes atypical cell death

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Preclinical and experimental research in thoracic tumors / By

Researchers from the Cell death group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Cristina Muñoz-Pinedo, have characterized the cell death process due to starvation, in which the endoplasmic reticulum plays a leading role. Their work, chosen as the cover of the latest Molecular and Cellular Biology journal, was carried out within TRAIN-ERs,

Starvation causes atypical cell death Read More »

IDIBELL and ICO researchers take part in RCD Espanyol’s Heath Day

Leave a Comment / Uncategorised / By

April 29th, at 6pm Health Day blood donation campaign free invitation for RCDE – Valencia Mejor sin Cáncer Public Health Agency, the Blood and Tissue Bank, the Red Cross, the Spanish Association against Cancer, IDIBELL, the Spanish Society of Pharmacists and Farmapericos, the Catalan Federation of Adapted Sports and Afrucat

IDIBELL and ICO researchers take part in RCD Espanyol’s Heath Day Read More »

Chemoresistance in breast cancer is associated with the modulation of tumor cell populations

Leave a Comment / Transformation and Metastasis / By

Researchers from the transformation and metastasis group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Eva González-Suárez, have been able to recreate and characterize the process of acquisition of resistance to chemotherapy in orthotopic animal models of breast cancer, unveiling the possibility of reversing this resistance after a period of rest from the

Chemoresistance in breast cancer is associated with the modulation of tumor cell populations Read More »

Researchers describe a new pathophysiological process of megalencephalic leukoencephalopathy (MLC) in astrocytes

Leave a Comment / Physiology and pathology of the functional relationship between glia and neurons  / By

Depolarization causes the formation of a ternary complex between GlialCAM, MLC1 and ClC-2 in astrocytes: implications in megalencephalic leukoencephalopathy.

Researchers describe a new pathophysiological process of megalencephalic leukoencephalopathy (MLC) in astrocytes Read More »

IDIBELL researchers look for new drugs against melanoma

Sin categorizar / By

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) participated in a study published recently in the by the journal Investigative Dermatology, entitled “AURORA A overexpression (AURKA) is driven by FOXM1 and MAPK / ERK activation in melanoma cells harbouring BRAF or NRAS mutations: Impact

IDIBELL researchers look for new drugs against melanoma Read More »

Scroll to Top